Passport available only for Chinese nationals
China has launched a system of “virus passports” to kickstart international travel, as Russia sealed its first deal on Tuesday to manufacture the Sputnik V jab in the European Union.
While other nations like Brazil and Mexico are still struggling to get the pandemic under control, Chinese citizens can download the new certificates and use them to enter and leave the country.
Hailed as the world’s first virus passport–similar schemes are also under discussion in the United States and the EU–but the Chinese scheme is not mandatory.
Furthermore, as it is only available for Chinese citizens, it is not yet clear how it could work internationally.
Europe, by contrast, is still struggling to step up its rollout, even if officials promise 100 million shots will enter the EU each month from April to June.
The EU’s industry commissioner Thierry Breton said Tuesday that the bloc’s vaccine strategy should this week be augmented with the addition of Johnson & Johnson’s single-shot jab.
With approval expected “within the next, hopefully, days or hours,” he said, that would bring the number of vaccines in use across the 27 member states to four, on top of ones from BioNTech/Pfizer, Moderna and AstraZeneca.
The EU was given an additional boost, with an announcement that 10 million doses of the Sputnik V jab would be produced in Italy in the second half of 2021.
While Russia’s provision of the shots around the world, including to some smaller EU countries, has been a coup for Moscow’s image, European Council president Charles Michel accused Moscow “propaganda”, using “highly limited but widely publicised operations to supply vaccines”.
Nevertheless, Sputnik V’s makers demanded an apology from the EU’s medicines regulator after a senior official warned member states against hastily authorising the jab, comparing emergency rollouts to “Russian roulette”.
The United States, the worst-hit country in the world, is also accelerating its vaccine roll-out, with the states of New York and Florida preparing to make Covid-19 vaccines available to people aged 60 and over.
Much of the world is still struggling to break the grip of a pandemic that has killed more than 2.6 million people in a little over a year.
More than 700,000 people have now lost their lives in Latin America and the Caribbean, with Brazil and Mexico accounting for the lion’s share of deaths.
In France, intensive care units at hospitals in the Paris region are nearly saturated with Covid-19 patients, health authorities warned, and doctors are now putting off non-urgent operations in order to free up more beds.
But there has been some progress in Africa, where Sudan became the latest country to begin inoculating health workers using shots received through the Covax initiative.
Tunisia also received its first major delivery of coronavirus vaccine doses Tuesday, almost a month later than expected, paving the way for the start of its inoculation campaign this week.
A day after International Women’s Day, World Health Organization (WHO) chief Dr Tedros Adhanom Ghebreyesus warned that violence against women “has been exacerbated by the pandemic”–although it was already “endemic in every country and culture”.
Worldwide, nearly one in three women and girls over the age of 15 — around 736 million people — have suffered violence at some time in their lives, mostly at the hands of intimate partners according to a WHO report.
Countries around the globe are also suffering disinformation attacks, with the Czech Republic especially exposed to false social media claims that vaccines can “change your DNA” or panic-inducing stories of seniors dying en masse after receiving the jab.
After years of immigration lies, “Covid arrived, and the amount of disinformation just exploded,” Bohumil Kartous, a spokesman for a network that aims to battle disinformation, told AFP.
In Ukraine, Health Minister Maksym Stepanov said the low number of people–19,000–who have been vaccinated in the first two weeks of the country’s push was down to “anti-vax hysteria” against the Covishield vaccine, an Indian-made version of the AstraZeneca jab.